Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Completed
- Conditions
- Allergies
- Registration Number
- NCT00453583
- Lead Sponsor
- UCB Pharma
- Brief Summary
This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4581
Inclusion Criteria
- Children from 2-12 included
- History of allergy
- Used an Antihistamine within market authorization
Exclusion Criteria
- Child not yet treated for the presented allergy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parent satisfaction on a 11-point scale duration of the study
- Secondary Outcome Measures
Name Time Method Physician satisfaction on an 11-point scale duration of the study Efficacy, tolerability and global satisfaction duration of the study
Trial Locations
- Locations (1)
UCB Pharma
🇺🇸Smyrna, Georgia, United States
UCB Pharma🇺🇸Smyrna, Georgia, United States